Logo

American Heart Association

  2
  0


Final ID: Sa3034

Cardiovascular Disease and Cancer Mortality by Cardiovascular Health: Life's Essential 8 in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study

Abstract Body (Do not enter title and authors here): Introduction: Cardiovascular disease (CVD) and cancer are the top 2 causes of death among US adults. Life’s Essential 8 (LE8) is an updated cardiovascular health (CVH) metric that includes many factors known to reduce cancer risk. It is unclear how LE8-quantified CVH relates to CVD and cancer mortality in a competing risk framework.

Methods: REGARDS recruited 30,239 Black and White adults from the 48 contiguous US states in 2003-07. We excluded individuals with prevalent CVD or cancer, missing LE8, or no follow-up. Baseline total LE8 scores were categorized as low (<50), moderate (50-79), or high CVH (≥80). Cause-specific hazard models estimated relative hazard of CVD and cancer mortality as competing risks, adjusting for age, sex, race, level of education, and region.

Results: Among 11,385 REGARDS participants who were free of CVD and cancer (mean [SD] age 65 [9] years, 52% women, 44% Black adults), 24%, 66%, and 10% had low, moderate, and high CVH, respectively. Over a median (IQR) follow-up of 14 (8-18) years, 8% died from CVD, 7% from cancer, and 17% from other causes. Moderate and high CVH were significantly associated with graded lower risk of CVD and cancer mortality after adjusting for potential confounders (Table). CVD mortality was lower across better physical activity, blood pressure, diet, sleep, smoking, and glucose CVH groupings. Cancer mortality was lower across better diet and smoking groupings.

Conclusion: LE8-quantified CVH was independently associated with lower CVD and cancer mortality in a competing risk framework and in graded fashion. These findings underscore the significance of lifestyle modifications in mortality risk reduction for the top 2 causes of death in the US, advocating for their incorporation into clinical guidelines and preventive counseling.
  • Huether, Katherine  ( University of Vermont , Colchester , Vermont , United States )
  • Pinheiro, Laura  ( Weill Cornell Medicine , New York , New York , United States )
  • Judd, Suzanne  ( UAB , Birmiham , Alabama , United States )
  • Long, Leann  ( Wake Forest School of Medicine , Winston Salem , North Carolina , United States )
  • Safford, Monika  ( WEILL CORNELL MEDICINE , New York , New York , United States )
  • Lloyd-jones, Donald  ( Northwestern University , Chicago , Illinois , United States )
  • Plante, Timothy  ( University of Vermont , Colchester , Vermont , United States )
  • Author Disclosures:
    Katherine Huether: No Answer | Laura Pinheiro: DO have relevant financial relationships ; Research Funding (PI or named investigator):Pfizer/Conquer Cancer Foundation:Active (exists now) ; Individual Stocks/Stock Options:Johnson and Johnson:Active (exists now) | Suzanne Judd: DO NOT have relevant financial relationships | Leann Long: DO NOT have relevant financial relationships | Monika Safford: No Answer | Donald Lloyd-Jones: DO NOT have relevant financial relationships | Timothy Plante: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Breaking Barriers: Addressing Health Disparities for Improved Outcomes

Saturday, 11/16/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available